Marizyme News and Activities

Marizyme is owned by Qualigen Therapeutics.

Qualigen Therapeutics is a company listed under the stock ticker QLGN (US).

They are in:

• Medical Equipment50%
• Biotechnology50%

View the org chart displaying its 12 main executives

Most searched biographies at Marizyme

• David Barthel, Chief Executive Officer and Director
• William Hearl, Independent Director
• Terry Brostowin, Director

Create your alert
to follow the executive moves at Marizyme.

Qualigen Therapeutics has 2,406 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).
• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).
• NewLimit has just announced a $435 Million fundraising (posted on June 3 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Valerie Hanote - Non-Executive Director at Eurofins

Learn more about the Biotechnology industry

Press releases by Marizyme

• Press Releases – Marizyme, Inc.

Social media about Marizyme

• Marizyme on Wikipedia, Google News & Yahoo Finance
• Marizyme on LinkedIn, X (Twitter) & YouTube